EUROAPI Releases 2024 Universal Registration Document Highlights

Author: Olivia Taylor Updated: 04-01-2025 11:45 AM

EUROAPI Publishes 2024 Universal Registration Document

EUROAPI has announced the release of its 2024 Universal Registration Document. This important document is now available in ESEF format as filed with the French Autorité des marchés financiers (AMF).

Key Components of the Document

The 2024 Universal Registration Document is comprehensive, offering a detailed overview that includes:

Annual Financial Report

This report encompasses the management report, which includes the Corporate Governance report, sustainability statements, and financial statements for the company, as well as consolidated statements.

Statutory Auditors’ Insights

Included in the document are the statutory auditors’ reports, providing critical evaluations and a special report focused on regulated agreements.

Fee Disclosure Information

Transparency is vital; thus, the document reviews disclosures relating to statutory auditors’ fees, ensuring stakeholders can assess auditor engagements.

Share Buy-Back Program Description

Investors can gain insights into the current share buy-back program, which plays a significant role in the company’s strategy.

Accessing the Report

Individuals interested in reviewing the document can find it on EUROAPI's official website and the AMF's platform, as it is available to the public according to the current regulatory frameworks.

About EUROAPI

EUROAPI stands at the forefront of the pharmaceutical industry, focusing on innovative solutions tailored to meet the growing global demand for active pharmaceutical ingredients. With a robust portfolio of about 200 products, the company excels in providing a variety of technologies while advancing the development of new and transformative molecules through its Contract Development and Manufacturing Organization (CDMO) activities.

The heart of EUROAPI's mission is improving health access worldwide. The dedicated team of 3,430 professionals is inspired daily by the goal of enabling crucial therapies. With strong research and development frameworks and six manufacturing sites across Europe, EUROAPI ensures the highest standards in API manufacturing. The company proudly offers services to a customer base spanning over 80 countries.

EUROAPI's commitment to excellence, while navigating the complexities of the pharmaceutical landscape, continues to solidify its position as a leader in this vital sector.

Contact Information

Media Relations:
Laurence Bollack
Tel.: +33 (0)6 81 86 80 19
Email: mr@euroapi.com

Investor Relations:
Sophie Palliez-Capian
Tel.: +33 (0)6 87 89 33 51
Email: Sophie.palliez@euroapi.com

Frequently Asked Questions

What is the purpose of the Universal Registration Document?

The document provides a comprehensive overview of EUROAPI's financial health, governance, and operational strategies.

Where can I find the 2024 Universal Registration Document?

The document is accessible on EUROAPI's official website as well as on the AMF’s platform.

What key information does the annual financial report include?

It includes the management report, corporate governance report, sustainability statements, and financial statements.

How does EUROAPI contribute to sustainable health solutions?

By innovating active ingredient solutions and ensuring access to essential therapies globally.

What is EUROAPI’s approach to quality manufacturing?

The company emphasizes high-quality manufacturing across all its facilities, complying with regulatory standards while supporting customer needs.

About The Author

Olivia Taylor here, a 26-year-old writer and financial advisor. After earning a degree in finance, I worked in the sector for years. I've always loved numbers and had a talent for simplifying difficult financial ideas so that anyone could understand. I wrote my first book because of this passion; it helps readers take charge of their financial futures by fusing real-life stories with useful financial advice.

Whether they are just beginning their careers, preparing for significant life events, or seeking to invest wisely, my goal with my writing is to enable people to make educated financial decisions. The foundation of my work is the conviction that security and freedom of the individual are largely determined by financial literacy. To further financial education, I run workshops and frequently write for financial blogs in addition to my books.

I like to travel, experience other cultures, and find inspiration in daily life when I'm not writing or examining market trends. My passion is utilizing sound financial practices to help people reach their financial objectives and lead the best lives possible.

Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.